{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:33:51Z","timestamp":1712795631513},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,10]]},"DOI":"10.7759\/cureus.57973","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T17:04:11Z","timestamp":1712768651000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Management of Atypical Hemolytic-Uremic Syndrome in Pregnancy Using Eculizumab: A Case Review"],"prefix":"10.7759","author":[{"given":"Faryal","family":"Altaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikail","family":"Khanzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anandu M","family":"Anto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misbahuddin","family":"Khaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32835df48a","article-title":"Complement disorders and hemolytic uremic syndrome","volume":"25","author":"Joseph C","year":"2013","unstructured":"Joseph C, Gattineni J. Complement disorders and hemolytic uremic syndrome. Curr Opin Pediatr. 2013, 25:209-15. 10.1097\/MOP.0b013e32835df48a","journal-title":"Curr Opin Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2019.388","article-title":"Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome","volume":"35","author":"Lee H","year":"2020","unstructured":"Lee H, Kang E, Kang HG, et al.. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome. Korean J Intern Med. 2020, 35:25-40. 10.3904\/kjim.2019.388","journal-title":"Korean J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09450912","article-title":"Obstetric nephrology: pregnancy and the kidney--inextricably linked","volume":"7","author":"August P","year":"2012","unstructured":"August P. Obstetric nephrology: pregnancy and the kidney--inextricably linked. Clin J Am Soc Nephrol. 2012, 7:2071-2. 10.2215\/CJN.09450912","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal JF","year":"2015","unstructured":"Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol. 2015, 67:56-70. 10.1016\/j.molimm.2015.02.030","journal-title":"Mol Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262890","article-title":"Plasmatherapy in atypical hemolytic uremic syndrome","volume":"36","author":"Loirat C","year":"2010","unstructured":"Loirat C, Garnier A, Sellier-Leclerc AL, Kwon T. Plasmatherapy in atypical hemolytic uremic syndrome. Semin Thromb Hemost. 2010, 36:673-81. 10.1055\/s-0030-1262890","journal-title":"Semin Thromb Hemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-023-06102-w","article-title":"Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement","volume":"39","author":"Wildes DM","year":"2024","unstructured":"Wildes DM, Harvey S, Costigan CS, Sweeney C, Twomey \u00c9, Awan A, Gorman KM. Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement. Pediatr Nephrol. 2024, 39:315-24. 10.1007\/s00467-023-06102-w","journal-title":"Pediatr Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac150","article-title":"Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan","volume":"38","author":"Ito S","year":"2023","unstructured":"Ito S, Hataya H, Ashida A, et al.. Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan. Nephrol Dial Transplant. 2023, 38:414-24. 10.1093\/ndt\/gfac150","journal-title":"Nephrol Dial Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri F","year":"2010","unstructured":"Fakhouri F, Roumenina L, Provot F, et al.. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol. 2010, 21:859-67. 10.1681\/ASN.2009070706","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01025-x","article-title":"Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a global aHUS registry analysis","volume":"34","author":"Fakhouri F","year":"2021","unstructured":"Fakhouri F, Scully M, Ardissino G, Al-Dakkak I, Miller B, Rondeau E. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a global aHUS registry analysis. J Nephrol. 2021, 34:1581-90. 10.1007\/s40620-021-01025-x","journal-title":"J Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003554","article-title":"Pregnancy-associated atypical hemolytic uremic syndrome: a systematic review","volume":"135","author":"Gupta M","year":"2020","unstructured":"Gupta M, Govindappagari S, Burwick RM. Pregnancy-associated atypical hemolytic uremic syndrome: a systematic review. Obstet Gynecol. 2020, 135:46-58. 10.1097\/AOG.0000000000003554","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference","volume":"91","author":"Goodship TH","year":"2017","unstructured":"Goodship TH, Cook HT, Fakhouri F, et al.. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference. Kidney Int. 2017, 91:539-51. 10.1016\/j.kint.2016.10.005","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4091-3","article-title":"Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use","volume":"34","author":"Wijnsma KL","year":"2019","unstructured":"Wijnsma KL, Duineveld C, Wetzels JF, van de Kar NC. Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use. Pediatr Nephrol. 2019, 34:2261-77. 10.1007\/s00467-018-4091-3","journal-title":"Pediatr Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25689","article-title":"Furosemide-induced thrombotic thrombocytopenic purpura: a report of a rare case","volume":"14","author":"Chandok T","year":"2022","unstructured":"Chandok T, Qureshi ZA, Yapor L, Khaja M. Furosemide-induced thrombotic thrombocytopenic purpura: a report of a rare case. Cureus. 2022, 14:e25689. 10.7759\/cureus.25689","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15790","article-title":"Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis","volume":"185","author":"Soci\u00e9 G","year":"2019","unstructured":"Soci\u00e9 G, Caby-Tosi MP, Marantz JL, et al.. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis. Br J Haematol. 2019, 185:297-310. 10.1111\/bjh.15790","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S245620","article-title":"Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management","volume":"16","author":"Yerigeri K","year":"2023","unstructured":"Yerigeri K, Kadatane S, Mongan K, et al.. Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management. J Multidiscip Healthc. 2023, 16:2233-49. 10.2147\/JMDH.S245620","journal-title":"J Multidiscip Healthc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23525","article-title":"Mitomycin-induced thrombotic thrombocytopenic purpura treated successfully with plasmapheresis and steroid: a case report","volume":"14","author":"Khaja M","year":"2022","unstructured":"Khaja M, Qureshi ZA, Kandhi S, Altaf F, Yapor L. Mitomycin-induced thrombotic thrombocytopenic purpura treated successfully with plasmapheresis and steroid: a case report. Cureus. 2022, 14:e23525. 10.7759\/cureus.23525","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02100-4","article-title":"A life-threatening case of pregnancy-related atypical haemolytic uremic syndrome and successful treatment with eculizumab","volume":"21","author":"Puri P","year":"2020","unstructured":"Puri P, Hanxhiu A, O'Hara DV, Hsu D, Vucak-Dzumhur M. A life-threatening case of pregnancy-related atypical haemolytic uremic syndrome and successful treatment with eculizumab. BMC Nephrol. 2020, 21:488. 10.1186\/s12882-020-02100-4","journal-title":"BMC Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi V","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al.. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013, 8:554-62. 10.2215\/CJN.04760512","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48898","article-title":"Ceftriaxone-induced thrombotic thrombocytopenic purpura treated successfully with plasmapheresis and eculizumab: a rare case report","volume":"15","author":"Qureshi ZA","year":"2023","unstructured":"Qureshi ZA, Altaf F, Khanzada M, Thet A, Espinosa L. Ceftriaxone-induced thrombotic thrombocytopenic purpura treated successfully with plasmapheresis and eculizumab: a rare case report. Cureus. 2023, 15:e48898. 10.7759\/cureus.48898","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244891-successful-management-of-atypical-hemolytic-uremic-syndrome-in-pregnancy-using-eculizumab-a-case-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T17:04:14Z","timestamp":1712768654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244891-successful-management-of-atypical-hemolytic-uremic-syndrome-in-pregnancy-using-eculizumab-a-case-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.57973","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,10]]}}}